Tower Research Capital (TRC)’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195 | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $5.27K | Sell |
|
|||||
|
2024
Q2 | $6.94K | Buy |
|
|||||
|
2024
Q1 | $5.99K | Sell |
|
|||||
|
2023
Q4 | $7.52K | Buy |
|
|||||
|
2023
Q3 | $3.06K | Buy |
|
|||||
|
2023
Q2 | $7.16K | Sell |
|
|||||
|
2023
Q1 | $9K | Buy |
|
|||||
|
2022
Q4 | $5K | Buy |
|
|||||
|
2022
Q3 | $6K | Sell |
|
|||||
|
2022
Q2 | $12K | Buy |
|
|||||
|
2022
Q1 | $2K | Sell |
|
|||||
|
2021
Q4 | $10K | Buy |
|
|||||
|
2021
Q3 | $10K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3K | Buy |
|